HEADER HYDROLASE/HYDROLASE INHIBITOR 13-SEP-00 1FTV TITLE THEORETICAL MODEL STRUCTURE OF ACTINIDIN WITH DIFFERENT TITLE 2 BIOLOGICALLY IMPORTANT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTINIDIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.22.14 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ACTINIDIA CHINENSIS; SOURCE 3 ORGANISM_COMMON: CHINESE GOOSEBERRY, KIWIFRUIT KEYWDS CYSTEINE PROTEINASE INHIBITOR , THIOL PROTEASE INHIBITOR, KEYWDS 2 HYDROLASE EXPDTA THEORETICAL MODEL AUTHOR S.BHATTACHARYA,A.BANERJEE REVDAT 1 25-OCT-00 1FTV 0 JRNL AUTH S.BHATTACHARYA,A.BERA,S.CHAKRABORTY,S.GHOSH, JRNL AUTH 2 A.BANERJEE JRNL TITL THEORETICAL MODEL STRUCTURE OF ACTINIDIN WITH JRNL TITL 2 DIFFERENT BIOLOGICALLY IMPORTANT INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.I.VARUGHESE,Y.SU,D.CROMWELL,S.HASNAIN,N.-H.XUONG REMARK 1 TITL CRYSTAL STRUCTURE OF ACTINIDIN-E-64 COMPLEX REMARK 1 REF BIOCHEMISTRY V. 31 5172 1992 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.YAMAMOTO,K.MATSUMOTO,H.OHISHI,T.ISHIDA,M.INOUE, REMARK 1 AUTH 2 K.KITAMURA,H.MIZUNO REMARK 1 TITL REFINED X-RAY STRUCTURE OF PAPAIN.E-64-C COMPLEX REMARK 1 TITL 2 AT 2.1-ANGSTROMS RESOLUTION REMARK 1 REF J.BIOL.CHEM. V. 266 14771 1991 REMARK 1 REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.N.BAKER REMARK 1 TITL STRUCTURE OF ACTINIDIN, AFTER REFINEMENT AT 1.7 REMARK 1 TITL 2 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 141 441 1980 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH N.A.KATERELOS,M.A.TAYLOR,M.SCOTT,P.W.GOODENOUGH, REMARK 1 AUTH 2 R.W.PICKERSGILL REMARK 1 TITL CRYSTAL STRUCTURE OF A CARICAIN D158E MUTANT IN REMARK 1 TITL 2 COMPLEX WITH E-64 REMARK 1 REF FEBS LETT. V. 392 35 1996 REMARK 1 REFN ASTM FEBLAL NE ISSN 0014-5793 REMARK 1 REFERENCE 5 REMARK 1 AUTH K.MATSUMOTO,D.YAMAMOTO,H.OHISHI,K.TOMOO,T.ISHIDA, REMARK 1 AUTH 2 M.INOUE,T.SADATOME,K.KITAMURA,H.MIZUNO REMARK 1 TITL MODE OF BINDING OF E-64-C, A POTENT THIOL PROTEASE REMARK 1 TITL 2 INHIBITOR, TO PAPAIN AS DETERMINED BY X-RAY REMARK 1 TITL 3 CRYSTAL ANALYSIS OF THE COMPLEX REMARK 1 REF FEBS LETT. V. 245 177 1989 REMARK 1 REFN ASTM FEBLAL NE ISSN 0014-5793 REMARK 1 REFERENCE 6 REMARK 1 AUTH D.YAMAMOTO,K.MATSUMOTO,H.OHISHI,T.ISHIDA,M.INOUE, REMARK 1 AUTH 2 K.KITAMURA,K.HANADA REMARK 1 TITL THE IMPORTANCE OF VAL-157 HYDROPHOBIC INTERACTION REMARK 1 TITL 2 FOR PAPAIN INHIBITORY ACTIVITY OF AN EPOXYSUCCINYL REMARK 1 TITL 3 AMINO ACID DERIVATIVE; A STRUCTURE-ACTIVITY REMARK 1 TITL 4 RELATIONSHIP BASED ON THE CRYSTAL STRUCTURE OF THE REMARK 1 TITL 5 PAPAIN-E-64-C COMPLEX REMARK 1 REF FEBS LETT. V. 253 134 1990 REMARK 1 REFN ASTM FEBLAL NE ISSN 0014-5793 REMARK 1 REFERENCE 7 REMARK 1 AUTH M.-J.KIM,D.YAMAMOTO,K.MATSUMOTO,M.INOUE,T.ISHIDA, REMARK 1 AUTH 2 H.MIZUNO,S.SUMIYA,K.KITAMURA REMARK 1 TITL CRYSTAL STRUCTURE OF PAPAIN-E64-C COMPLEX. BINDING REMARK 1 TITL 2 DIVERSITY OF E64-C TO PAPAIN S2 AND S3 SUBSITES REMARK 1 REF BIOCHEM.J. V. 287 797 1992 REMARK 1 REFN ASTM BIJOAK UK ISSN 0306-3275 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER BIOSYM INSIGHT II 95.0 REMARK 3 AUTHORS : MSI REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE MODEL BUILDING WAS DONE WITH THE REMARK 3 HELP OF BIOSYM INSIGHT II 95.0 USING DOCKING AND DISCOVER REMARK 3 PLATFORM REMARK 4 REMARK 4 1FTV COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-OCT-2000. REMARK 100 THE RCSB ID CODE IS RCSB011894. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 87 CG CD OE1 OE2 REMARK 470 TYR A 218 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 60 -105.96 60.41 REMARK 500 ASP A 185 166.03 63.71 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C7X RELATED DB: PDB REMARK 900 1C7X CONTAINS CARICAIN COMPLEXED WITH ZPACK REMARK 900 RELATED ID: 1EUX RELATED DB: PDB REMARK 900 1EUX CONTAINS CARICAIN COMPLEXED WITH E64C REMARK 900 RELATED ID: 1F1I RELATED DB: PDB REMARK 900 1F1I CARICAIN COMPLEXED WITH LEUPEPTIN REMARK 900 RELATED ID: 1F3Q RELATED DB: PDB REMARK 900 1F3Q ACTINIDIN COMPLEXED WITH ZPACK REMARK 900 RELATED ID: 1FOG RELATED DB: PDB REMARK 900 1FOG ACTINIDIN COMPLEXED WITH LEUPEPTIN DBREF 1FTV A 1 218 UNP P00785 ACTN_ACTCH 127 344 SEQADV 1FTV VAL A 100 UNP P00785 LEU 226 CONFLICT SEQADV 1FTV ALA A 101 UNP P00785 ASP 227 CONFLICT SEQADV 1FTV GLN A 146 UNP P00785 HIS 272 CONFLICT SEQRES 1 A 218 LEU PRO SER TYR VAL ASP TRP ARG SER ALA GLY ALA VAL SEQRES 2 A 218 VAL ASP ILE LYS SER GLN GLY GLU CYS GLY GLY CYS TRP SEQRES 3 A 218 ALA PHE SER ALA ILE ALA THR VAL GLU GLY ILE ASN LYS SEQRES 4 A 218 ILE VAL THR GLY VAL LEU ILE SER LEU SER GLU GLN GLU SEQRES 5 A 218 LEU ILE ASP CYS GLY ARG THR GLN ASN THR ARG GLY CYS SEQRES 6 A 218 ASN GLY GLY TYR ILE THR ASP GLY PHE GLN PHE ILE ILE SEQRES 7 A 218 ASN ASN GLY GLY ILE ASN THR GLU GLU ASN TYR PRO TYR SEQRES 8 A 218 THR ALA GLN ASP GLY GLU CYS ASN VAL ALA LEU GLN ASN SEQRES 9 A 218 GLU LYS TYR VAL THR ILE ASP THR TYR GLU ASN VAL PRO SEQRES 10 A 218 TYR ASN ASN GLU TRP ALA LEU GLN THR ALA VAL THR TYR SEQRES 11 A 218 GLN PRO VAL SER VAL ALA LEU ASP ALA ALA GLY ASP ALA SEQRES 12 A 218 PHE LYS GLN TYR SER SER GLY ILE PHE THR GLY PRO CYS SEQRES 13 A 218 GLY THR ALA ILE ASP HIS ALA VAL THR ILE VAL GLY TYR SEQRES 14 A 218 GLY THR GLU GLY GLY ILE ASP TYR TRP ILE VAL LYS ASN SEQRES 15 A 218 SER TRP ASP THR THR TRP GLY GLU GLU GLY TYR MET ARG SEQRES 16 A 218 ILE LEU ARG ASN VAL GLY GLY ALA GLY THR CYS GLY ILE SEQRES 17 A 218 ALA THR MET PRO SER TYR PRO VAL LYS TYR HET E6C A 219H 22 HETNAM E6C N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2- HETNAM 2 E6C METHYL-BUTANE FORMUL 2 E6C C15 H28 N2 O5 HELIX 1 1 GLY A 24 GLY A 43 1 20 HELIX 2 2 SER A 49 GLY A 57 1 9 HELIX 3 3 ARG A 63 GLY A 67 5 5 HELIX 4 4 TYR A 69 GLY A 81 1 13 HELIX 5 5 ASN A 99 GLU A 105 1 7 HELIX 6 6 ASN A 120 GLN A 131 1 12 HELIX 7 7 GLY A 141 GLN A 146 1 6 HELIX 8 8 GLY A 204 ILE A 208 5 5 SHEET 1 A 5 ILE A 151 PHE A 152 0 SHEET 2 A 5 TYR A 193 LEU A 197 1 O ARG A 195 N PHE A 152 SHEET 3 A 5 ILE A 175 LYS A 181 -1 N TRP A 178 O ILE A 196 SHEET 4 A 5 HIS A 162 GLU A 172 -1 O THR A 165 N LYS A 181 SHEET 5 A 5 VAL A 5 ASP A 6 -1 N VAL A 5 O TYR A 169 SHEET 1 B 5 ILE A 151 PHE A 152 0 SHEET 2 B 5 TYR A 193 LEU A 197 1 O ARG A 195 N PHE A 152 SHEET 3 B 5 ILE A 175 LYS A 181 -1 N TRP A 178 O ILE A 196 SHEET 4 B 5 HIS A 162 GLU A 172 -1 O THR A 165 N LYS A 181 SHEET 5 B 5 VAL A 133 LEU A 137 -1 O VAL A 133 N ILE A 166 SHEET 1 C 2 THR A 112 ASN A 115 0 SHEET 2 C 2 SER A 213 VAL A 216 -1 O TYR A 214 N GLU A 114 SSBOND 1 CYS A 22 CYS A 65 SSBOND 2 CYS A 56 CYS A 98 SSBOND 3 CYS A 156 CYS A 206 LINK C2 E6C A 219H SG CYS A 25 CISPEP 1 GLY A 154 PRO A 155 0 -2.56 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 0.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 0.000000 0.00000 MASTER 111 0 1 8 12 0 0 6 0 0 0 17 END